A new paradigm for cancer immunotherapy: Orchestrating type 1 and type 2 immunity for curative response
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Clinical and Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ctm2.70154 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832586767294791680 |
|---|---|
| author | Bing Feng Li Tang |
| author_facet | Bing Feng Li Tang |
| author_sort | Bing Feng |
| collection | DOAJ |
| format | Article |
| id | doaj-art-0f505102e7da48d6a852496c9e668683 |
| institution | Kabale University |
| issn | 2001-1326 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical and Translational Medicine |
| spelling | doaj-art-0f505102e7da48d6a852496c9e6686832025-01-25T04:00:38ZengWileyClinical and Translational Medicine2001-13262025-01-01151n/an/a10.1002/ctm2.70154A new paradigm for cancer immunotherapy: Orchestrating type 1 and type 2 immunity for curative responseBing Feng0Li Tang1Institute of Bioengineering École Polytechnique Fédérale de Lausanne (EPFL) Lausanne SwitzerlandInstitute of Bioengineering École Polytechnique Fédérale de Lausanne (EPFL) Lausanne Switzerlandhttps://doi.org/10.1002/ctm2.70154cancer immunotherapycurative responseType 2 immunity |
| spellingShingle | Bing Feng Li Tang A new paradigm for cancer immunotherapy: Orchestrating type 1 and type 2 immunity for curative response Clinical and Translational Medicine cancer immunotherapy curative response Type 2 immunity |
| title | A new paradigm for cancer immunotherapy: Orchestrating type 1 and type 2 immunity for curative response |
| title_full | A new paradigm for cancer immunotherapy: Orchestrating type 1 and type 2 immunity for curative response |
| title_fullStr | A new paradigm for cancer immunotherapy: Orchestrating type 1 and type 2 immunity for curative response |
| title_full_unstemmed | A new paradigm for cancer immunotherapy: Orchestrating type 1 and type 2 immunity for curative response |
| title_short | A new paradigm for cancer immunotherapy: Orchestrating type 1 and type 2 immunity for curative response |
| title_sort | new paradigm for cancer immunotherapy orchestrating type 1 and type 2 immunity for curative response |
| topic | cancer immunotherapy curative response Type 2 immunity |
| url | https://doi.org/10.1002/ctm2.70154 |
| work_keys_str_mv | AT bingfeng anewparadigmforcancerimmunotherapyorchestratingtype1andtype2immunityforcurativeresponse AT litang anewparadigmforcancerimmunotherapyorchestratingtype1andtype2immunityforcurativeresponse AT bingfeng newparadigmforcancerimmunotherapyorchestratingtype1andtype2immunityforcurativeresponse AT litang newparadigmforcancerimmunotherapyorchestratingtype1andtype2immunityforcurativeresponse |